A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer
Authors
Keywords
-
Journal
Gynecologic Oncology
Volume 178, Issue -, Pages 110-118
Publisher
Elsevier BV
Online
2023-10-14
DOI
10.1016/j.ygyno.2023.09.013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
- (2023) Ramez N. Eskander et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
- (2023) Mansoor R. Mirza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab in Patients With Microsatellite Instability–High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study
- (2022) David M. O'Malley et al. JOURNAL OF CLINICAL ONCOLOGY
- Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
- (2020) Vicky Makker et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Biomarkers in Endometrial Cancer: A Systematic Review and Meta-Analysis
- (2020) Eva Coll-de la Rubia et al. Journal of Clinical Medicine
- Novel Oral mTORC1/2 Inhibitor TAK-228 Has Synergistic Antitumor Effects When Combined with Paclitaxel or PI3Kα Inhibitor TAK-117 in Preclinical Bladder Cancer Models
- (2019) Anna Hernández-Prat et al. MOLECULAR CANCER RESEARCH
- Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
- (2019) Aurelien Marabelle et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of doxorubicin after progression on carboplatin and paclitaxel in advanced or recurrent endometrial cancer: a retrospective analysis of patients treated at the Brazilian National Cancer Institute (INCA)
- (2018) Emeline Moreira et al. MEDICAL ONCOLOGY
- Cancer of the corpus uteri
- (2018) Frédéric Amant et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- A phase II evaluation of ixabepilone in the treatment of recurrent/persistent carcinosarcoma of the uterus, an NRG Oncology/Gynecologic Oncology Group study
- (2017) Carolyn K. McCourt et al. GYNECOLOGIC ONCOLOGY
- Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1–Positive Endometrial Cancer: Results From the KEYNOTE-028 Study
- (2017) Patrick A. Ott et al. JOURNAL OF CLINICAL ONCOLOGY
- New use of microsatellite instability analysis in endometrial cancer
- (2017) Haruko Kunitomi et al. Oncology Letters
- TAK-228 (formerly MLN0128), an investigational oral dual TORC1/2 inhibitor: A phase I dose escalation study in patients with relapsed or refractory multiple myeloma, non-Hodgkin lymphoma, or Waldenström's macroglobulinemia
- (2016) Irene M. Ghobrial et al. AMERICAN JOURNAL OF HEMATOLOGY
- Classification and characterization of microsatellite instability across 18 cancer types
- (2016) Ronald J Hause et al. NATURE MEDICINE
- MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem/ progenitor cells
- (2016) Zhihong Zeng et al. Oncotarget
- ESMO–ESGO–ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up
- (2015) Nicoletta Colombo et al. RADIOTHERAPY AND ONCOLOGY
- Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: A gynecologic oncology group study
- (2014) Gini F. Fleming et al. GYNECOLOGIC ONCOLOGY
- Impact of microsatellite instability on survival of endometrial cancer patients
- (2014) Daiva Kanopienė et al. Medicina-Lithuania
- The Emerging Genomic Landscape of Endometrial Cancer
- (2013) M. Le Gallo et al. CLINICAL CHEMISTRY
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study
- (2011) Carol Aghajanian et al. JOURNAL OF CLINICAL ONCOLOGY
- High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein Stability
- (2011) Lydia W.T. Cheung et al. Cancer Discovery
- A predictive probability design for phase II cancer clinical trials
- (2008) J Jack Lee et al. Clinical Trials
- A phase II trial of weekly 1-hour paclitaxel as second-line therapy for endometrial and cervical cancer
- (2008) Howard D. Homesley et al. International Journal of Clinical Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started